Supply Chain Intelligence

Tempest Therapeutics, Inc. Supply Chain

TPST supply chain intelligence for Tempest Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

TPST ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

9Suppliers
0Customers
3Debt Items
20Related Chains

Tempest Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
ERIGEN ERIGEN 92% On February 3, 2026, the Company completed the acquisition of the Erigen Assets (the 'Erigen Closing') under the Asset Purchase Agreement (the 'Asset Acquisition') and issued to Erigen 8,268,495 shar…
FACTOR-BIOSCIENCE-LIMITED FACTOR-BIOSCIENCE-LIMITED 92% We are obligated to pay Factor Bioscience Limited up to $40 million in total upon achievement of certain development milestones for the programs.
H-C-WAINWRIGHT-CO-LLC H-C-WAINWRIGHT-CO-LLC 92% Pursuant to an engagement letter, H.C. Wainwright & Co., LLC (the “ Placement Agent ”) acted as the exclusive placement agent in connection with the foregoing transaction, and the Company issued to t…
NOVATIM NOVATIM 92% We are obligated to pay Novatim up to $80 million in total upon achievement of certain development milestones for the programs and up to $1.24 billion in total upon achievement of certain commercial …
FACTOR FACTOR 85% Pursuant to the Asset Purchase Agreement, Factor has made a funding commitment (the 'Funding Commitment') to provide the Company
COMPUTERSHARE-TRUST-COMPANY-NA COMPUTERSHARE-TRUST-COMPANY-NA 80% The descriptions and terms of the Rights are set forth in a Rights Agreement, dated as of October 10, 2023 (the 'Rights Agreement'), between the Company and Computershare Trust Company, NA.
CMOS CMOS 75% We enter into contracts in the normal course of business with equipment and reagent vendors, CROs, CMOs and other third parties for clinical trials, preclinical research studies and testing and manuf…
CROS CROS 75% We enter into contracts in the normal course of business with equipment and reagent vendors, CROs, CMOs and other third parties for clinical trials, preclinical research studies and testing and manuf…
EQUIPMENT-AND-REAGENT-VENDORS EQUIPMENT-AND-REAGENT-VENDORS 75% We enter into contracts in the normal course of business with equipment and reagent vendors, CROs, CMOs and other third parties for clinical trials, preclinical research studies and testing and manuf…

Tempest Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Tempest Therapeutics, Inc..

Tempest Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
TPST-DEBT-13083 Warrants outstanding: 6784989 90% xbrl warrant detail from xbrl 2026-02-03.
TPST-DEBT Debt stack $8.1M 90% Market cache reports total debt of $8.1M.
TPST-DEBT-13084 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-12-31.

Tempest Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Tempest Therapeutics, Inc..

Tempest Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
TPST-OWNER-VERSANT-VENTURE-MANAGEMENT-LLC Versant Venture Management, LLC 90% 13F overlay lists Versant Venture Management, LLC as top holder; 1 tracked holders.

Tempest Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
GSK GSK plc 100.00 2
HOWL Werewolf Therapeutics, Inc. 100.00 2
COGT Cogent Biosciences, Inc. 100.00 2
RXRX Recursion Pharmaceuticals, Inc. 100.00 2
IMNM Immunome, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
CRSP CRISPR Therapeutics AG 100.00 2
BIAF bioAffinity Technologies, Inc. 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
TECX Tectonic Therapeutic, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
CABA Cabaletta Bio, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
ATYR aTyr Pharma, Inc. 100.00 2
ELVN Enliven Therapeutics, Inc. 100.00 2
GH Guardant Health, Inc. 100.00 2
View TPST supply chain intel →

Explore the full interactive supply chain map for Tempest Therapeutics, Inc..

Open TPST supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map